chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A legal complaint was received from an attorney alleging that a male child received series of Hib-TITER, Acel-Imune, and hepatitis B vaccines from Aug 21, 1997 through July 7, 1999 and subsequently "suffered devastating injuries through mercury toxicity and associated complications and sequelae and the aggravation of other conditions directly through exposure, via intramuscular injection of mercury" in the "thimerosal-containing vaccination." According to the legal complaint, the child "was born a perfectly normal, healthy boy whose APGAR scores at birth were well within the normal range." It is alleged that at approximately 28 months of age, the child "was neurologically devastated by the accumulation of Mercury in his body, having been exposed via intramuscular vaccinations, and suddenly regressed developmentally, losing milestones of neurological development previously achieved, specifically including, but not limited to becoming withdrawn, unable to speak, unresponsive to his environment, engaging in repetitive behavior and the loss of language skills." According to the legal complaint, the child "suffered severe and permanent injuries" and "sustained and will sustain in the the future a mental, intellectual, developmental and neurological incapacity and associated learning disabilities, affect disorders and impairments." The reporter also noted that the child was exposed to mercury in utero via his mother who received Rh(D) immune globulin while she was pregnant.
Patient received an MMR vaccine on 6/27/16. On 7/7/16 patient started to develop a fever, and the next day a rash. Patient also develop sore throat, rash and eye irritation. Physician diagnosed as Measles. Product was MMR vaccine from Merck Lot # L041457.
This spontaneous report was received from a physician and refers to a patient of unknown demographics. No pertinent medical history, concurrent conditions or concurrent conditions were reported. On an unknown date in MAY 2015, the patient was vaccinated with an expired dose of PNEUMOVAX, (lot number was unknown, expiration date was reported as an unspecified date in March 2015), via subcutaneous route. There were no known adverse effects reported. The outcome of expired product administered was unknown. No further information was provided. Additional information has been requested.
Pt woke up AM not move arm, headache, burning fever took TYLENOL et alternate with MOTRIN worse by noon malaise, chills, fever, shaking by 700 still high fever. Healthcare professional considered going hospital w/ fever. Broken 50 hours from getting shot.
Cold chills, cough, muscle aches, swelling at injection site, dizziness, body aches, headache, fatigue
Booster dose; The lymph swelling in my breast and under arm area/ lymph node swelling under her arm; Arm pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 45 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE X; MANUFACTUERER UNKNOWN), for COVID-19 immunization. The following information was reported: IMMUNISATION (non-serious), outcome "unknown", described as "Booster dose"; LYMPHADENOPATHY (non-serious), outcome "recovered", described as "The lymph swelling in my breast and under arm area/ lymph node swelling under her arm"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "Arm pain". Therapeutic measures were taken as a result of lymphadenopathy.  Additional information: Reporter Subtype: Patient. PQC Present: No. AE Present: Yes. Caller received her Pfizer BTC vaccine (purple cap formula) Booster dose and experienced lymph node swelling under her arm and also arm pain. Wanted to know if this was normal. Caller stated she "did exercises to drain her lymphatic system and her mother said to put a hot compress on it and the next morning it was gone." Caller was asking if she needed to worry about getting breast cancer now, because of "the lymph swelling in her breast and under arm area. A review of the Prescribing Information for Pfizer BTC vaccine (purple cap formula) failed to find any information regarding breast cancer. Please consult with your doctor or health care provider for further guidance, as your doctor/healthcare provider is the most familiar with your medical condition.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Swollen wrist first left with pain then right followed by constant pain in both thumbs hands falling asleep, tingling, on going body stiffness
nearly entire leg swelled to twice normal size, was hot & red, temperature 103 degrees.
she and her husband received the first Pfizer Covid 19 Vaccine on 12April2021. They both felt tired after the vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 58 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 12Apr2021 (Lot number: EW0151) at the age of 57 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "no" (unspecified if ongoing). There were no concomitant medications. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "she and her husband received the first Pfizer Covid 19 Vaccine on 12April2021. They both felt tired after the vaccine". Relevant laboratory tests and procedures are available in the appropriate section.  Additional Information: Caller reports that she and her husband received the first Pfizer Covid 19 Vaccine on 12April2021. They both felt tired after the vaccine  No follow-up attempts are possible. No further information is expected.
30 minutes after my first vaccine shot I started feeling numbness in my lower lip. It started to creep up the side of my face - the same side as my shot. Within an hour the whole side of my face was numb, I had a pounding headache, and was really dizzy, light headed, and nauseous. After a few phone calls to the clinic, my doctor, and urgent care, I went into the ER. At the ER they first made sure it wasn't a stroke, that was their main concern.  It wasn't.  They ended up diagnosing me with a migraine (I have never had a migraine in my life).  Through an IV they gave me Diphenhydramine, ketorolac, and prochlorperazine.  I went home several hours later still feeling awful.  But since that day I have been plagued with daily headaches and sporadic facial numbness. I am having a hard time finding a doctor who will see me because they don't know anything about reactions to the vaccine.
patient given third dose of Pfizer when intended dose was to be anthrax. patient second dose was may 19, 2021.  patient left stable from site with no adverse reaction noted at time of discharge? patient advised to seek guidance from PCM if anything arises.
Narrative:  Patient reports that he developed shingles (painful rash on the left flank) shortly after receiving first zoster immunization. Patient reported to the ED on 9/24/20 (vaccine was given on 7/28/20) and was diagnosed with shingles given rx for Valtrex.
I had chills, aches, and fatigue.  I started menstruation 2 days early and have had a very heavy period with lots of clotting. Filling a super+ tampon every hour-hour and a half.
She feels so tired basically like fatigue; This is a spontaneous report from a contactable consumer. This consumer (parent) reported for a female patient (daughter) of an unknown age received second dose of BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, solution for injection, batch/lot number: unknown, Expiry Date: unknown), via an unspecified route of administration on an unknown date as dose 2 ,single for Covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received first dose of BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, solution for injection, batch/lot number: unknown), via an unspecified route of administration on an unknown date as historical vaccine as single dose for Covid-19 immunisation. On an unspecified date, the patient got the second one yesterday, she feels so tired like really fatigue. The outcome of the adverse event was unknown.  Reason for no lot number: Reporter stated, I don't see a LOT# on here. It just looks like healthcare professional clinic site. So, it is EW and I think this is 0196, I think, I don't know if this is 0 or O, I don't know. When paraphrased reporter's name as (Name withheld), reporter stated, "Yes." (complete name not appropriately paraphrased and clarified further, hence only initials for reporter's name captured in tab).Further probing could not be initiated as reporter was unwilling to further answer the questions. Hence, other details were unknown and limited information was available over the call.  Information on the lot/batch number has been requested.
Arm pain to point of requiring ice Tiredness Low grade fever (99.5) Achiness  and joint pain (This was second dose-first dose had similar results).   Still experiencing side effects 20 hours later.
Expired vaccine used (Expired drug administered). A non-serious spontaneous report of administration of expired FLUMIST was received from a nurse concerning a 31-year-old male. Neither medical history nor concomitant medications were reported. On 12-Jan-2009, the patient received expired FLUMIST vaccine. The vaccine had an expiration date of 11-Jan-2009. There was no adverse events associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved. Based on the results of the investigation, the root cause for the medication errors were caused by 1) customers not discarding product from the previous season and 2) product expiring during the peak of the flu season resulting in some medication errors that occurred shortly after the product expired. Additional information was received on 18-Mar-2009 that indicated no adverse events were reported through the medical clinic and patient demographic information was received. Additional information was received on 12-May-2009: product complaint investigation results.
Case number PHHY2015US157126 is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 600795) website on 24 Nov 2015. This report refers to a female patient of an unknown age. Medical history and concomitant medications were not reported. The patient was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) in 2009. Post vaccination the patient experienced lip swelling. Outcome of the event was recovered. The reporter assessed the event as non-serious. Causality of the event was unknown. Further the patient was vaccinated with Flu nasal mist (manufacturer and batch number: not reported) and seasonal influenza vaccine (manufacturer and batch number: not reported) in 2010 and 2012 respectively and experienced lip swelling after each time after vaccination (see case: PHHY2015US157129).
Itch rash at injection site that extend down patients arm. Patient to take oral Benadryl.
Seizure activity after finishing 4 injections. Tonic-clonic symptoms resolved. Pt refused further medical workup. Pt had not had breakfast prior to appt.
This medically confirmed report (initial receipt 27-APR-2012) concerns a female patient. On 24-APR-2012 the patient received AFLURIA (batch no. 1169AA) intramuscularly. On an unspecified date the patient experienced cellulitis. The patient was a hospital in-patient at the time of the event. The event did not result in the hospitalisation. The patient was treated with Vancomycin. The outcome for the event was recovering.
Experiencing horrible and debilitating headaches; Her jaw and neck feel sore; Her jaw and neck feel sore; This is a spontaneous report from a non-contactable consumer (patient herself) via a medical information team. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: Unknown, Expiration date: Unknown) via an unspecified route of administration, first dose on an unspecified date, second dose on an unspecified date; Both as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that, consumer said it has already been a month since she received her 2nd dose of the Pfizer-BioNTech COVID-19 Vaccine, and until now she was still experiencing horrible and debilitating headaches. She wants to know if this was an allergy. Consumer also added that her jaw and neck feel sore on an unspecified date and wants to know if this was associated with the vaccine or if this was just a reaction to the Prolia injection she gets twice a year. Referred the consumer to her healthcare professional for more guidance. Consumer said she already took Tylenol to treat her headache, but it did not work so she switched to Naproxen instead. The medication was now helping, but the headache eventually comes back. The outcome of the events was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
I had left wrist pain distributed up my arm that was severe for 4 days, I've had issues with that before and that seemed to flare it. I took Tylenol and rested it and it got better after about 4 days, I saw the Dr 5 days later and he gave me a splint
Fever 102. F; nasal congestion, nasal drng, cough; body aches, headache.
contact dermatitis; arm has now changed into a red rectangle that has texture to it; red area at the injection site; hard area at the injection site; warm area at the injection site; swollen area at the injection site; This case was reported by a nurse via call center representative and described the occurrence of injection site erythema in a 59-year-old female patient who received Herpes zoster (Shingrix) (batch number 5J27J, expiry date unknown) for prophylaxis.   On 19th May 2022, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. In May 2022, less than 2 weeks after receiving Shingrix, the patient experienced contact dermatitis and skin texture abnormal. On 20th May 2022, the patient experienced injection site erythema, injection site induration, injection site warmth and injection site swelling. On an unknown date, the outcome of the injection site erythema, injection site induration, injection site warmth and injection site swelling were recovered/resolved and the outcome of the contact dermatitis and skin texture abnormal were unknown.   The reporter considered the injection site erythema, injection site induration, injection site warmth, injection site swelling, contact dermatitis and skin texture abnormal to be related to Shingrix.     Additional Information: GSK Receipt Date: 27-MAY-2022 Reporter's Comment: The patient self-reported this case. The patient received dose of Shingrix vaccine in the left deltoid and on the following day she developed a red, hard, warm, swollen area at the injection site that stayed like that for about 5 to 6 days. The patient stated that during the time when her arm was swollen, she iced it and wrapped it for 2 days (while at work).  That same area of her arm had now changed into a red rectangle that had texture to it. The patient also stated that area now it looked like a contact dermatitis. The patient did not have the expiration date of the vaccine but did have the lot number.  The reporter consented to follow-up.
consumer reports that pt exp severe swelling @ inj site following vax; afeb; no hives present; MD considering DT for pts next vax;
I have had tachycardia events much more frequently and up to 1-2x/week; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 34 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 19Feb2021 13:00 (Lot number: EL8982) at the age of 34 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EN6200, Location of injection: Arm Right, Vaccine Administration Time: 09:00 AM, Route of Administration: Intramuscular), administration date: 29Jan2021, when the patient was 34 years old, for COVID-19 immunization. The following information was reported: TACHYCARDIA (non-serious) with onset 20Feb2021 12:00, outcome "recovered with sequelae" (2021), described as "I have had tachycardia events much more frequently and up to 1-2x/week". Therapeutic measures were not taken as a result of tachycardia.  Additional information- The patient had no other significant health changes, no medications, no major lifestyle changes, no changes in caffeine consumption. The only variable  had this year was the two doses of the vaccine, and obviously it could be coincidental, but the patient scared to get a booster. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. There was no list of any other medications the patient received within 2 weeks of vaccination. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
29DEC pt devel rash;described by parent as bright red, sl raised, itching, lots of dots on pt's stomach, neck, back, under arms, legs, behind knees;pt given Antihistamine by parent for itching
Nausea and vomitting began after second dose. Patient also started a new medication, Rebylsus, the same time he recieved the injections. Nausea and vomitting progressed despite discontinuing the medication. Eventually diagnosed with esophageal adenocarcinoma
Big red angry rash at the injection site about the size of the palm of my hand,; Terrible headache; Low grade fever; Hot; Flu like Symptoms; Achy feeling; Itchy; Nausea; Very sore; Warm; Feeling horrible; Still feel miserable; Covid arm reaction 8 days later; Trunk rash right after the vaccine; Malaise; Soreness; Redness; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ERYTHEMA (Redness), VACCINATION SITE RASH (Big red angry rash at the injection site about the size of the palm of my hand,), RASH (Trunk rash right after the vaccine), HEADACHE (Terrible headache) and PYREXIA (Low grade fever) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy (Takes  Xyzal, Promethazine and a monthly shot of Xolair for allergy as suggested by her allergist based on her medical history.). Concomitant products included LEVOCETIRIZINE DIHYDROCHLORIDE (XYZAL), PROMETHAZINE and OMALIZUMAB (XOLAIR) for Allergy.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced ERYTHEMA (Redness), RASH (Trunk rash right after the vaccine), PAIN (Soreness) and MALAISE (Malaise). On 24-Feb-2021, the patient experienced INJECTION SITE RASH (Covid arm reaction 8 days later). On an unknown date, the patient experienced VACCINATION SITE RASH (Big red angry rash at the injection site about the size of the palm of my hand,), HEADACHE (Terrible headache), PYREXIA (Low grade fever), NAUSEA (Nausea), PAIN (Very sore), INJECTION SITE PAIN (Hot), INFLUENZA LIKE ILLNESS (Flu like Symptoms), PAIN (Achy feeling), PRURITUS (Itchy), VACCINATION SITE WARMTH (Warm), FEELING ABNORMAL (Feeling horrible) and FEELING ABNORMAL (Still feel miserable). The patient was treated with PARACETAMOL (TYLENOL) at a dose of unknown and FEXOFENADINE HYDROCHLORIDE (ALLEGRA) at a dose of unknown. At the time of the report, ERYTHEMA (Redness), VACCINATION SITE RASH (Big red angry rash at the injection site about the size of the palm of my hand,), RASH (Trunk rash right after the vaccine), HEADACHE (Terrible headache), PYREXIA (Low grade fever), INJECTION SITE RASH (Covid arm reaction 8 days later), NAUSEA (Nausea), PAIN (Very sore), PAIN (Soreness), INJECTION SITE PAIN (Hot), INFLUENZA LIKE ILLNESS (Flu like Symptoms), PAIN (Achy feeling), PRURITUS (Itchy), MALAISE (Malaise), VACCINATION SITE WARMTH (Warm), FEELING ABNORMAL (Feeling horrible) and FEELING ABNORMAL (Still feel miserable) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient also stated it is not a bad as it was 2 days ago.; Reporter's Comments: Treatment taken was Tyenol and Allegra
After receiving Pfizer booster, patient felt faint and passed-out. Patient experienced some convulsions during the time. Paramedics called to the scene. Patient was fine after a few minutes and left unharmed.
(Note: You'll want to contact my doctor to verify which flu vaccine I was given. The records I have access to only say "Influenza (IM) Preservative Free.")  -Soreness in both arms within two hours of receiving vaccines on 9/24/20 -Within four hours, could no longer lift either arm -Within four hours, small pink welts appeared on right arm surrounding place where flu vaccine was administered -Within four hours, soreness of throat and shortness of breath -By evening (about 6:00 pm), neither arm can be touched without flinching and outcry, though pain is significantly worse in right arm  -9/25/20: Uvula swollen (light purple) and extreme hoarseness (approximately 7:30 am) -Still could not raise arms without great pain. Welts on right arm have grown in size, swollen, combined into two large welts, turned red, and seem to be hives. Even the brush of a shirt sleeve causes great pain. (Noted at approximately 7:30 am) -Approximately 10 am: left arm seems to have recovered. Left arm can move normally without pain.  -Rests. Cannot walk across a room without labored breathing.   -Labored breathing worsens. Fatigue. Forehead feels warm. Left arm feels fine; right arm in great pain. Rests all morning. (approximately 9 am) -Red-ish, purple patch the size of a half dollar coin appeared on chest (approximately 11:45 am) -By approximately 4 pm, redness on chest has turned pink, barely visible -Treated with one  Equate Allergy Relief pill (Diphenhydramine HCI, 25 mg) on 9/26/20  (approximately 4 pm) -Drowsiness, assumed to be a result of the pill. (Approximately 4:30 pm) -Woke up covered in sweat: head, chest, arms, back, stomach, legs. Fever had broken. Could touch area of right arm affected by hives (hives still present) without flinching, though some pain was still present. Pinkness on chest no longer visible. Blood sugar had dropped to 35. Treated blood sugar with snack. (6:20 pm)  -As of now (10:23 am on 9/27/20), hives have disappeared in region of right arm where vaccine was administered, though the site is still tender. Throat is still hoarse. Uvula still swollen.
Pt. c/o itching and hives on back, torso and arms Sunday 10/12/03 at aprox. 10:00am.  Pt was given Benadryl by his parents on Suday at aprox. 10:00 am and parent-pt- reports that pt noticed a decrease in itching and hives.  Pt along with father presents today 10/14/04 at 9:00am with c/o of red raised areas  noted on Rt upper arm and upper back.  Encouraged parent to take pt to Doctor.  10/22/03 T.C. to fatherl and he reports that child was seen by Dr. on 10/16/03 and was put on Alegra180 mg one tablet x4days.  Father of child reports hives gone on 10/18/03.
2 days after the vaccine, my left eye became swollen and red. No pain, itching or other noticeable changes. Disappeared after 3 days onset, gradually getting better.
(R) arm swelling/redness/pain --> tender axillary edemopathy possible cellulitis